PMV Pharmaceuticals, Inc (PMVP) is a publicly traded Healthcare sector company. As of September 24, 2026, PMVP trades at $1.37 with a market cap of $80.72M and a P/E ratio of -0.98. PMVP moved -9.27% today. Year to date, PMVP is +11.38%; over the trailing twelve months it is -0.72%. Its 52-week range spans $0.81 to $1.88. Analyst consensus is strong buy with an average price target of $4.20. Rallies surfaces PMVP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PMVP shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.37 |
| Market Cap | $80.72M |
| P/E Ratio | -0.98 |
| EPS | $-1.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.88 |
| 52-Week Low | $0.81 |
| Volume | 513.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.48M |
| Net Income | $-75.22M |
| Gross Margin | 0.00% |
5 analysts cover PMVP: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.20.